marketwatch: "new migraine drugs have promise -- and a ,500 price tag." .
experts say years of cuts to nhs budgets and staff has led to patients waiting longer for chemotherapy and radiotherapy. .
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.� .